Toradol (Ketorolac) Should Be Avoided in Preeclampsia
Avoid NSAIDs, including Toradol (ketorolac), in women with preeclampsia, especially in the setting of acute kidney injury (AKI), and use alternative pain relief instead. 1
Why NSAIDs Are Problematic in Preeclampsia
The most recent and authoritative guideline from the International Society for the Study of Hypertension in Pregnancy (ISSHP) 2018 explicitly recommends against NSAIDs for postpartum analgesia in women with preeclampsia 1. This recommendation is particularly strong when:
- Renal impairment is present (preeclampsia commonly causes AKI)
- Placental abruption has occurred
- Other AKI risk factors exist (sepsis, postpartum hemorrhage)
The concern stems from NSAIDs' effects on renal prostaglandins, which can worsen kidney function in patients whose renal perfusion is already compromised by preeclampsia. While the guideline acknowledges some controversy exists—with observational studies suggesting the risk may be small—the recommendation errs on the side of caution until prospective randomized trials provide definitive evidence 1.
FDA Contraindications
The FDA drug label for Toradol provides additional critical context. Ketorolac is absolutely contraindicated in labor and delivery because it may adversely affect fetal circulation and inhibit uterine contractions 2. It is also contraindicated in patients with advanced renal impairment and those at risk for renal failure due to volume depletion 2—both conditions highly relevant to preeclampsia, where patients have capillary leak and are at increased risk for AKI 1.
Recommended Analgesic Alternatives
For pain control in preeclamptic patients, use:
First-Line Options:
- Acetaminophen (paracetamol) - safest option for mild-to-moderate pain 3
- Opioids (morphine, hydromorphone, oxycodone) - for moderate-to-severe pain requiring stronger analgesia 3
Special Considerations:
- Remifentanil PCA has been studied specifically in preeclamptic patients for labor analgesia and demonstrated effectiveness with minimal maternal and neonatal side effects 4
- Epidural analgesia remains the preferred method for labor pain in preeclamptic patients when not contraindicated 4
Clinical Algorithm
When managing pain in a patient with preeclampsia:
- Check renal function (creatinine, urine output)
- Assess for AKI risk factors (oliguria, elevated creatinine, placental abruption, hemorrhage)
- If any renal concerns exist: Absolutely avoid NSAIDs including ketorolac
- For mild-moderate pain: Use acetaminophen as first-line
- For severe pain: Use opioids (morphine, hydromorphone, oxycodone)
- Monitor blood pressure closely as some women develop severe hypertension from NSAIDs 1
Common Pitfalls to Avoid
- Don't assume "just one dose" is safe - even short-term NSAID use can precipitate AKI in vulnerable preeclamptic patients
- Don't use ketorolac peripartum - it's FDA-contraindicated in labor/delivery 2
- Don't overlook volume status - preeclamptic patients have capillary leak and reduced intravascular volume despite appearing edematous, making them particularly vulnerable to NSAID-induced renal injury 1
- Remember the 5-day maximum - even in non-pregnant patients, ketorolac is limited to ≤5 days due to serious adverse event risk 2
The evidence consistently points toward avoiding NSAIDs in preeclampsia and using safer alternatives like acetaminophen and opioids for adequate pain control.